Systemic Genetic Medicines for Hard-to-Treat Cancers
The numbers also emphasize the critical need for ongoing investment in research and innovation. The global oncology drug…
Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs
These statistics underscore the importance of sustained investment in research and development. The global oncology drugs market was…
Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs
These statistics underscore the importance of sustained investment in research and development. The global oncology drugs market was…
3 Promising Genomics Stocks to Keep an Eye On in 2025
An updated edition of the May 21, 2025, article. The promising field of genomics has undergone rapid evolution…
SpliceBio Secures $135 Million Series B Financing to Advance Lead Program SB-007 in Stargardt Disease and Expand Pipeline of Genetic Medicines
Financing co-led by new investors EQT Life Sciences and Sanofi Ventures, with participation from Roche Venture Fund, as…